• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    American Vanguard Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    6/9/25 9:16:41 AM ET
    $AVD
    Agricultural Chemicals
    Industrials
    Get the next $AVD alert in real time by email
    8-K
    AMERICAN VANGUARD CORP false 0000005981 0000005981 2025-06-06 2025-06-06
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (date of earliest event reported): June 6, 2025

     

     

    AMERICAN VANGUARD CORPORATION

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-13795   95-2588080

    (State or other jurisdiction

    of incorporation)

     

    Commission

    File Number

     

    (I.R.S. Employer

    Identification No.)

    4695 MacArthur Court

    Newport Beach, California 92660

    (Address of principal executive offices)

    Registrant’s telephone number: (949) 260-1200

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading

    Symbol

     

    Exchanges

    on which registered

    Common Stock, $.10 par value   AVD   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b02 of the Securities Exchange Act of 1934 (§240.12b02 of this chapter).

    Emerging Growth Company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 3.01

    Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

    As previously reported, on April 2, 2025, American Vanguard Corporation (the “Company”) received a notice of noncompliance from the New York Stock Exchange (the “NYSE”) noting that the Company was not in compliance with Section 802.01E of the NYSE Listed Company Manual due to the delayed filing of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”).

    On June 6, 2025, the Company received written notice from NYSE Regulation closing this matter and confirming that the Company had regained compliance with Section 802.01E of the NYSE Listed Company Manual. The notice followed the Company filing the Form 10-K and its Form 10-Q for the fiscal quarter ended March 31, 2025.

     

    Item 7.01

    Regulation FD Disclosure.

    On June 6, 2025, the Company held its previously announced earnings call regarding its unaudited financial results for the three-month period ended March 31, 2025. A transcript of the earnings call is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    The information furnished under Item 7.01 and Item 9.01 of this Current Report on Form 8-K, including Exhibit 99.1 to this Current Report on Form 8-K, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liabilities under that Section, nor shall it be deemed incorporated by reference in any registration statement or other filings of the Company under the Securities Act of 1933, as amended, or into another filing under the Exchange Act, except as shall be set forth by specific reference in such filing.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit 99.1    Transcript of Earnings Call held on June 6, 2025.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

    2


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

        AMERICAN VANGUARD CORPORATION
    Date: June 9, 2025  
        By:  

    /s/ David T. Johnson

          David T. Johnson
          Chief Financial Officer

     

    3

    Get the next $AVD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVD

    DatePrice TargetRatingAnalyst
    7/22/2024$14.00Buy
    Lake Street
    More analyst ratings